Skip to main content
All lobbying filings

Danaher Corporation

Danaher Corporation filed a Q4 report for Danaher Corporation on January 19, 2026.

Lobbying for Danaher Corporation · health care products developer and manufacturer

As filed: DANAHER CORPORATION for DANAHER CORPORATION.

All filings by Danaher Corporation · Everything Danaher Corporation has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 19, 2026
Expenses
$160,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Issues related to biotechnology, cell and gene therapy

General issues related to tariffs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem